These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
694 related articles for article (PubMed ID: 28918490)
1. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy. Li L; Tang P; Li S; Qin X; Yang H; Wu C; Liu Y Med Oncol; 2017 Sep; 34(10):180. PubMed ID: 28918490 [TBL] [Abstract][Full Text] [Related]
2. Notch signaling pathway and cancer metastasis. Hu YY; Zheng MH; Zhang R; Liang YM; Han H Adv Exp Med Biol; 2012; 727():186-98. PubMed ID: 22399348 [TBL] [Abstract][Full Text] [Related]
3. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells. Espinoza I; Miele L Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264 [TBL] [Abstract][Full Text] [Related]
4. Targeting Notch signaling for cancer therapeutic intervention. Shao H; Huang Q; Liu ZJ Adv Pharmacol; 2012; 65():191-234. PubMed ID: 22959027 [TBL] [Abstract][Full Text] [Related]
5. Regulation of EMT by Notch signaling pathway in tumor progression. Li Y; Ma J; Qian X; Wu Q; Xia J; Miele L; Sarkar FH; Wang Z Curr Cancer Drug Targets; 2013 Nov; 13(9):957-62. PubMed ID: 24168187 [TBL] [Abstract][Full Text] [Related]
6. Notch, apoptosis and cancer. Dang TP Adv Exp Med Biol; 2012; 727():199-209. PubMed ID: 22399349 [TBL] [Abstract][Full Text] [Related]
7. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer. Brechbiel J; Miller-Moslin K; Adjei AA Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036 [TBL] [Abstract][Full Text] [Related]
8. Cross-regulation between Notch signaling pathway and miRNA machinery in cancer. Majidinia M; Darband SG; Kaviani M; Nabavi SM; Jahanban-Esfahlan R; Yousefi B DNA Repair (Amst); 2018; 66-67():30-41. PubMed ID: 29723707 [TBL] [Abstract][Full Text] [Related]
9. Notch -- a goldilocks signaling pathway in disease and cancer therapy. Braune EB; Lendahl U Discov Med; 2016 Mar; 21(115):189-96. PubMed ID: 27115169 [TBL] [Abstract][Full Text] [Related]
10. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Shi Q; Xue C; Zeng Y; Yuan X; Chu Q; Jiang S; Wang J; Zhang Y; Zhu D; Li L Signal Transduct Target Ther; 2024 May; 9(1):128. PubMed ID: 38797752 [TBL] [Abstract][Full Text] [Related]
11. Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis. Misiorek JO; Przybyszewska-Podstawka A; Kałafut J; Paziewska B; Rolle K; Rivero-Müller A; Nees M Cells; 2021 Jan; 10(1):. PubMed ID: 33430387 [TBL] [Abstract][Full Text] [Related]
12. Molecular pathways: translational and therapeutic implications of the Notch signaling pathway in cancer. Previs RA; Coleman RL; Harris AL; Sood AK Clin Cancer Res; 2015 Mar; 21(5):955-61. PubMed ID: 25388163 [TBL] [Abstract][Full Text] [Related]
13. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Wang Z; Li Y; Kong D; Sarkar FH Curr Drug Targets; 2010 Jun; 11(6):745-51. PubMed ID: 20041844 [TBL] [Abstract][Full Text] [Related]
14. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines. Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102 [TBL] [Abstract][Full Text] [Related]
16. Exploitation of the Notch signaling pathway as a novel target for cancer therapy. Wang Z; Li Y; Banerjee S; Sarkar FH Anticancer Res; 2008; 28(6A):3621-30. PubMed ID: 19189643 [TBL] [Abstract][Full Text] [Related]
17. Modulating Notch signaling by pathway-intrinsic and pathway-extrinsic mechanisms. Poellinger L; Lendahl U Curr Opin Genet Dev; 2008 Oct; 18(5):449-54. PubMed ID: 18722525 [TBL] [Abstract][Full Text] [Related]
18. Notch signaling: an emerging therapeutic target for cancer treatment. Yuan X; Wu H; Xu H; Xiong H; Chu Q; Yu S; Wu GS; Wu K Cancer Lett; 2015 Dec; 369(1):20-7. PubMed ID: 26341688 [TBL] [Abstract][Full Text] [Related]
19. Notch signaling: emerging molecular targets for cancer therapy. Yin L; Velazquez OC; Liu ZJ Biochem Pharmacol; 2010 Sep; 80(5):690-701. PubMed ID: 20361945 [TBL] [Abstract][Full Text] [Related]
20. Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures. Locatelli M; Curigliano G Curr Opin Oncol; 2017 Nov; 29(6):411-427. PubMed ID: 28914645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]